Dean J. Mitchell, Director at Praxis Precision Medicines, Inc. (PRAX), bought 50,000 shares at $0.84 ($42K) on 2023-03-24, disclosed to the SEC on 2023-03-27.
Open-market purchase of $42k PRAX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| XON | BUY | 2017-08-11 | $183K | — | Filing → |
| IMGN | BUY | 2015-11-18 | $125K | — | Filing → |
| ALO | BUY | 2008-03-04 | $73K | — | Filing → |